Abaxis Inc (ABAX) 52.00 $ABAX Abaxis: Growth on Test

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 8:14 PM

Abaxis Inc (ABAX) 52.00 $ABAX

Abaxis: Growth on Test Menu Expansion; Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:38AM CDT
Abaxis (ABAX) has been working on expanding its portfolio of rapid test menu over the recent past.
BSX: 23.77 (-0.13), ICUI: 115.74 (+0.74), ABAX: 52.00 (+1.05), NUVA: 61.57 (+0.75)

Point of Care (PoC) Lipid Test Market Size & Forecast By Instruments (Brand Market Sizing: Roche Reflotron, Roche Cobas b 101, Abaxis Piccolo, Alere Cholestech LDX, Alere Afinion, Samsung LABGEO, PTS CardioChek), By Application (Hyperlipidemia, Hypertrigl
PR Newswire - Wed Jun 22, 4:33PM CDT
Global Point of care (PoC) Lipid Test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period.
ABAX: 52.00 (+1.05)

Abaxis Global Diagnostics and AAHA Develop Preventive Care Testing Initiative
PR Newswire - Mon Jun 06, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today announced a partnership with the American Animal Hospital Association (AAHA) to develop a wellness testing initiative that is focused on improving compliance for blood diagnostic testing.
ABAX: 52.00 (+1.05)

Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 115.74 (+0.74), ABAX: 52.00 (+1.05), LMAT: 13.64 (-0.06), NUVA: 61.57 (+0.75)

Abaxis, Inc. to Present at the Jefferies 2016 Global Healthcare Conference
PR Newswire - Wed Jun 01, 7:02AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, chief financial officer, will present at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016 at 10:30 a.m. ET. The conference will be held at the Grand Hyatt in New York City.
ABAX: 52.00 (+1.05)

New Strong Sell Stocks for May 31st
Swarup Gupta - Zacks Investment Research - Tue May 31, 8:27AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
ABAX: 52.00 (+1.05), ASB: 17.20 (+0.09), AHT: 5.71 (+0.15), CIT: 33.18 (+0.64), MATX: 33.51 (-0.25)

Abaxis, Inc. to Present at the Stifel 2016 Dental & Veterinary Conference
PR Newswire - Wed May 25, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, chief financial officer, will present at the Stifel 2016 Dental & Veterinary Conference on Wednesday, June 1, 2016 at 8:00 a.m. ET. The conference will be held at The Peninsula Hotel in New York City.
ABAX: 52.00 (+1.05)

Abaxis (ABAX) Posts Solid Q4 amid International Headwind
Zacks Equity Research - Zacks Investment Research - Wed May 25, 5:28AM CDT
On May 18, 2016, we issued an updated research report on Abaxis, Inc. (ABAX).
ICUI: 115.74 (+0.74), ABAX: 52.00 (+1.05), LMAT: 13.64 (-0.06), NUVA: 61.57 (+0.75)

New Strong Sell Stocks for May 12th
Zacks Equity Research - Zacks Investment Research - Thu May 12, 6:59AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
ABC: 82.18 (+0.26), ABAX: 52.00 (+1.05), AMID: 12.17 (+0.27), ABBV: 64.35 (+0.19), FCCY: 12.00 (+0.17)

Global Biochip Market Worth USD 18.4 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: 3Qbd, Abaxis Inc, Emulate Inc - Research and Markets
BusinessWire - Thu May 05, 4:36AM CDT
Research and Markets has announced the addition of the "Global Biochip Markets: Microarrays and Lab-on-a-Chip" report to their offering.
ABAX: 52.00 (+1.05)

Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 23.77 (-0.13), CAPR: 4.10 (+0.08), CSII: 19.32 (-0.30), ABAX: 52.00 (+1.05)

Abaxis tops Street 4Q forecasts
Automated Insights - Thu Apr 28, 4:49PM CDT
UNION CITY, Calif. (AP) _ Abaxis Inc. (ABAX) on Thursday reported fiscal fourth-quarter earnings of $8.9 million.
ABAX: 52.00 (+1.05)

Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2016 and Declares a 9% Increase in Quarterly Cash Dividend
PR Newswire - Thu Apr 28, 3:01PM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the fourth quarter and fiscal year ended March 31, 2016.
ABAX: 52.00 (+1.05)

Abaxis To Report Fourth Quarter And Fiscal Year 2016 Financial Results On Thursday, April 28, 2016
PR Newswire - Tue Apr 19, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets, has scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2016, ended March 31, 2016. The call will be at 4:15 p.m. ET on Thursday, April 28, 2016. The Company will report financial results for the fourth quarter and fiscal year 2016 after the market closes on Thursday, April 28, 2016.
ABAX: 52.00 (+1.05)

Global Veterinary Diagnostics Market Report 2014-2022 - Analysis, Technologies & Forecasts - Key Vendors: Abaxis, HESKA, IDEXX Labs - Research and Markets
BusinessWire - Tue Apr 12, 7:26AM CDT
Research and Markets has announced the addition of the "Veterinary Diagnostics Global Market Analysis - Forecast (2014-2022)" report to their offering.
ABAX: 52.00 (+1.05)

Global Blood Gas and Electrolyte Analyzer Industry
PR Newswire - Mon Apr 04, 6:43PM CDT
This report analyzes the worldwide markets for Blood Gas and Electrolyte Analyzers in Units and US$ Thousand by the following Product Segments: Blood Gas Analyzers (Benchtop Analyzers, & Point-of-Care Analyzers), and Electrolyte Analyzers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as -
ABAX: 52.00 (+1.05)

23.6% Return Seen to Date on SmarTrend Abaxis Call (ABAX)
Comtex SmarTrend(R) - Wed Mar 02, 11:51AM CST
SmarTrend identified a Downtrend for Abaxis (NASDAQ:ABAX) on January 11th, 2016 at $51.04. In approximately 2 months, Abaxis has returned 23.63% as of today's recent price of $38.98.
ABAX: 52.00 (+1.05)

Abaxis Down 21.1% Since SmarTrend Downtrend Call (ABAX)
Comtex SmarTrend(R) - Mon Feb 08, 4:31PM CST
SmarTrend identified a Downtrend for Abaxis (NASDAQ:ABAX) on January 11th, 2016 at $51.04. In approximately 4 weeks, Abaxis has returned 21.14% as of today's recent price of $40.25.
ABAX: 52.00 (+1.05)

Abaxis Down 13.2% Since SmarTrend Downtrend Call (ABAX)
Comtex SmarTrend(R) - Mon Feb 01, 11:43AM CST
SmarTrend identified a Downtrend for Abaxis (NASDAQ:ABAX) on January 11th, 2016 at $51.04. In approximately 3 weeks, Abaxis has returned 13.19% as of today's recent price of $44.31.
ABAX: 52.00 (+1.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bambu Lab Shakes Up 3D Printing with Massive Discounts

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...

Dan-O's Seasoning Bags $25M to Spice Up Global Kitchens

Spicing Up The Investment Scene Who would've thought a humble seasoning mix could steal the show in the investment world, eh? Dan-O's Seasoning, that quirky little flavor brand from Louisville, just pulled a $25 million rabbit out of the hat with an investment from The Newcastle Network. That's news worth chewing on. From Farmers Market to Flavor Giant Let's flash back a...

Denver Arts Week: A Cultural Extravaganza Returns

Denver's got its art game on again, folks—a sprawling fiesta for the senses called Denver Arts Week is making its return from November 6 to 15. Pack your bags, grab a parka, or whatever you need to brace the Colorado chill, as this ain't just any regular art crawl—it's a full-blown celebration with nearly 300 events jam-packed across the city. If you blink, Denver...

Matt Gennone Takes Helm as CEO of evolv Consulting

New Leadership for a New Era When Matt Gennone steps into the CEO office at evolv Consulting, the game changes. It's like swapping horses midstream but with someone who knows every ripple and current. Coming from Fractal, with a past that's nothing short of a masterclass in analytics and consulting, he's poised to take evolv by the reins. A Veteran in Analytics Matt hails...

TIER IV and TUM Drive Level 4 Autonomous Cars

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Limber Health's New Tool Set to Revolutionize Rehab

A Shift in Rehab Therapy Alright, it's not every day you see a seismic shift in the world of rehab therapy. Limber Health just dropped the mic with their brand-new Recovery Forecast. Built on the heftiest risk-adjusted patient outcomes database in the game, this tool aims to replace those old-school, single-snapshot forecasts with a full 90-day predictive outlook. If you...

GAC Revamps its Charge into Europe's EV Market

A New Chapter in GAC's European Journey GAC isn’t tiptoeing into Europe; the Chinese automaker hit the ground running with the launch of its AION UT and AION V in Italy. This isn't just another car release. Oh no, it’s GAC's grand entrance into a market saturated with well-established players. On October 8th, amidst the artistic vibes of Milan’s Superstudio Più,...

RISION Launches Torix: Affordable Thermal Imaging

A Thermal Leap Forward Ah, technology. Especially when it promises a new and shiny gadget that does more and costs less. Folks, RISION just threw another wrench in the works of the personal thermal imaging market. Their latest piece of kit, the RISION Torix, is now in the spotlight. Yep, we're talking about a handheld thermal camera that vows not to suck your wallet dry...

SportsMed Expands with Hoboken Clinic Opening

SportsMed's Strategic Hoboken Leap The healthcare landscape in New Jersey and Connecticut's about to get a shake-up, and all eyes should be on SportsMed Physical Therapy. They've just planted their flag in Hoboken with a new clinic, bumping their operational presence up to a whopping 57 clinics. Quite the comeback story from their humble beginnings. Now, that's some...

From Samhain to Spooktacular: Ireland's Halloween Origins

Tracing Halloween's Roots: A Journey to Ireland The chill in the air can only mean one thing—Halloween is creeping up on us. But amid all the plastic pumpkins and supermarket candy, have you ever stopped to wonder where it all began? Well, folks, lace up your boots because Ireland is calling, and it's got more than a pot of gold at the end of this rainbow. No, the real...